Dectin-1 expression in TAMs promoted their suppression of anti-tumor immunity and toleration of tumor cells in pancreatic ductal adenocarcinoma, making Dectin-1 an interesting target for immunotherapy (94). The gene discussed is CLEC7A; the disease is pancreatic ductal adenocarcinoma.